Charlotte Chamberlain

1.5k total citations · 1 hit paper
32 papers, 869 citations indexed

About

Charlotte Chamberlain is a scholar working on Public Health, Environmental and Occupational Health, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Charlotte Chamberlain has authored 32 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 10 papers in General Health Professions and 9 papers in Economics and Econometrics. Recurrent topics in Charlotte Chamberlain's work include Palliative Care and End-of-Life Issues (19 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Economic and Financial Impacts of Cancer (8 papers). Charlotte Chamberlain is often cited by papers focused on Palliative Care and End-of-Life Issues (19 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Economic and Financial Impacts of Cancer (8 papers). Charlotte Chamberlain collaborates with scholars based in United Kingdom, United States and Norway. Charlotte Chamberlain's co-authors include William Hollingworth, Jenny Donovan, Amanda Owen‐Smith, Lucy Selman, Ryann Sowden, Jonathan Koffman, Steve Marshall, Sophie Papa, James Spicer and Richard Sullivan and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Charlotte Chamberlain

28 papers receiving 844 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A systematic review of geographical variation in access to chemotherapy

2015 332 citations Charlotte Chamberlain, Amanda Owen‐Smith et al. BMC Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charlotte Chamberlain United Kingdom	12	240	190	188	160	150	32	869
Gem M. Le United States	22	377 1.6×	187 1.0×	104 0.6×	56 0.3×	262 1.7×	44	1.1k
Adhra Al‐Mawali Oman	18	110 0.5×	175 0.9×	151 0.8×	59 0.4×	122 0.8×	41	898
Salim M. Adib Lebanon	18	210 0.9×	133 0.7×	59 0.3×	45 0.3×	163 1.1×	53	895
Tsang‐Wu Liu Taiwan	20	370 1.5×	509 2.7×	125 0.7×	34 0.2×	195 1.3×	52	1.2k
Ibtihal Fadhil Lebanon	19	310 1.3×	271 1.4×	63 0.3×	143 0.9×	215 1.4×	40	1.2k
George Laking New Zealand	14	161 0.7×	165 0.9×	32 0.2×	73 0.5×	78 0.5×	41	880
Hannah R. Abrams United States	8	268 1.1×	81 0.4×	66 0.4×	108 0.7×	253 1.7×	18	731
Ni Gong China	15	133 0.6×	118 0.6×	49 0.3×	39 0.2×	216 1.4×	64	756
Ikram Burney Oman	19	310 1.3×	76 0.4×	115 0.6×	21 0.1×	182 1.2×	121	1.2k
Hala T. Borno United States	15	300 1.3×	203 1.1×	80 0.4×	158 1.0×	122 0.8×	78	744

Countries citing papers authored by Charlotte Chamberlain

Since Specialization

Citations

This map shows the geographic impact of Charlotte Chamberlain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Chamberlain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Chamberlain more than expected).

Fields of papers citing papers by Charlotte Chamberlain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Chamberlain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Chamberlain. The network helps show where Charlotte Chamberlain may publish in the future.

Co-authorship network of co-authors of Charlotte Chamberlain

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Chamberlain. A scholar is included among the top collaborators of Charlotte Chamberlain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Chamberlain. Charlotte Chamberlain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Droney, Joanne, Lynn Calman, Dipesh P Gopal, et al.. (2025). UK Association of Supportive Care in Cancer (UKASCC) Enhanced Supportive Care (ESC) National Collaborative: Building a Community of Practice. BMJ Supportive & Palliative Care. 16(1). 103–108.

Chamberlain, Charlotte, et al.. (2024). Hospice inpatient care models: cross-sectional inequality survey. BMJ Supportive & Palliative Care. 14(e3). e2519–e2522.

Chamberlain, Charlotte, Rhian Daniel, Guy Schofield, et al.. (2023). Right needle, right patient, right time? A national flash-mob audit of thromboprophylaxis in palliative care. Thrombosis Research. 223. 95–101. 2 indexed citations

Dewhurst, Felicity, et al.. (2023). Qualified and motivated, but limited by specialty-specific barriers: a national survey of UK Palliative Medicine consultants research experience. BMJ Supportive & Palliative Care. 14(1). 76–86. 1 indexed citations

Chamberlain, Charlotte, et al.. (2022). Acute hospital specialist palliative care: multidisciplinary team models and workforce in South West England. BMJ Supportive & Palliative Care. 14(e1). e484–e487. 2 indexed citations

Etkind, Simon, et al.. (2022). UK Palliative trainees Research Collaborative (UK-PRC): the first 5 years – 0–100 study sites. BMJ Supportive & Palliative Care. 14(e3). e3024–e3032. 3 indexed citations

Aggarwal, Ajay, et al.. (2021). Modelling palliative and end-of-life resource requirements during COVID-19: implications for quality care. BMJ Open. 11(5). e043795–e043795. 9 indexed citations

Dewhurst, Felicity, et al.. (2021). Palliative Medicine Specialist Trainee Research experience, interest and opportunities: a national survey. BMJ Supportive & Palliative Care. 14(e3). e2452–e2456. 2 indexed citations

Selman, Lucy, et al.. (2020). Bereavement Support on the Frontline of COVID-19: Recommendations for Hospital Clinicians. Journal of Pain and Symptom Management. 60(2). e81–e86. 165 indexed citations

10.

Rodin, Gary, Camilla Zimmermann, Danielle Rodin, et al.. (2020). COVID-19, palliative care and public health. European Journal of Cancer. 136. 95–98. 17 indexed citations

11.

Spicer, James, Charlotte Chamberlain, & Sophie Papa. (2020). Provision of cancer care during the COVID-19 pandemic. Nature Reviews Clinical Oncology. 17(6). 329–331. 76 indexed citations

12.

Chamberlain, Charlotte, Amanda Owen‐Smith, Fiona MacKichan, Jenny Donovan, & William Hollingworth. (2019). “What’s fair to an individual is not always fair to a population”: A qualitative study of patients and their health professionals using the Cancer Drugs Fund. Health Policy. 123(8). 706–712. 5 indexed citations

13.

Lewison, Grant, Ajay Aggarwal, Philip Roe, et al.. (2018). UK newspaper reporting of the NHS cancer drugs fund, 2010 to 2015: a retrospective media analysis. Journal of the Royal Society of Medicine. 111(10). 366–373. 4 indexed citations

14.

Aggarwal, Ajay, Tito Fojo, Charlotte Chamberlain, Courtney Davis, & Richard Sullivan. (2017). Do patient access schemes for high-cost cancer drugs deliver value to society?—lessons from the NHS Cancer Drugs Fund. Annals of Oncology. 28(8). 1738–1750. 80 indexed citations

15.

Hollingworth, William & Charlotte Chamberlain. (2017). Re: Do NICE's recommendations for disinvestment add up?. 1 indexed citations

16.

Dixon, Padraig, Charlotte Chamberlain, & William Hollingworth. (2016). Did It Matter That the Cancer Drugs Fund Was Not NICE? A Retrospective Review. Value in Health. 19(6). 879–884. 11 indexed citations

17.

Chamberlain, Charlotte, Amanda Owen‐Smith, Jenny Donovan, & William Hollingworth. (2015). A systematic review of geographical variation in access to chemotherapy. BMC Cancer. 16(1). 1–1. 332 indexed citations breakdown →

18.

Chamberlain, Charlotte, Simon M. Collin, Peter Stephens, et al.. (2014). Does the cancer drugs fund lead to faster uptake of cost-effective drugs? A time-trend analysis comparing England and Wales. British Journal of Cancer. 111(9). 1693–1702. 18 indexed citations

19.

Chamberlain, Charlotte, Richard M. Martin, John Busby, et al.. (2013). Trends in procedures for infertility and caesarean sections: was NICE disinvestment guidance implemented? NICE recommendation reminders. BMC Public Health. 13(1). 112–112. 24 indexed citations

20.

Chamberlain, Charlotte, Pål Romundstad, Lars J. Vatten, David Gunnell, & Richard M. Martin. (2010). The association of weight gain during adulthood with prostate cancer incidence and survival: A population‐based cohort. International Journal of Cancer. 129(5). 1199–1206. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact